Brooks W H, Latta R B, Mahaley M S, Roszman T L, Dudka L, Skaggs C
J Neurosurg. 1981 Mar;54(3):331-7. doi: 10.3171/jns.1981.54.3.0331.
Long-term assessment of general host immunocompetence of patients with primary malignant brain tumors indicates that although isolated determinations of nonspecific responsiveness are not clinically useful, sequential analyses utilizing a linear combination of in vitro lymphocyte probes are capable of predicting tumor recurrence prior to clinical deterioration.
对原发性恶性脑肿瘤患者总体宿主免疫能力的长期评估表明,尽管单独测定非特异性反应性在临床上并无用处,但利用体外淋巴细胞检测的线性组合进行连续分析能够在临床恶化之前预测肿瘤复发。